From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:2rk2.jpg|left|200px]] | + | {{Seed}} |
| | + | [[Image:2rk2.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_2rk2| PDB=2rk2 | SCENE= }} | | {{STRUCTURE_2rk2| PDB=2rk2 | SCENE= }} |
| | | | |
| - | '''DHFR R-67 complexed with NADP'''
| + | ===DHFR R-67 complexed with NADP=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | Type II dihydrofolate reductase (DHFR) is a plasmid-encoded enzyme that confers resistance to bacterial DHFR-targeted antifolate drugs. It forms a symmetric homotetramer with a central pore which functions as the active site. Its unusual structure, which results in a promiscuous binding surface that accommodates either the dihydrofolate (DHF) substrate or the NADPH cofactor, has constituted a significant limitation to efforts to understand its substrate specificity and reaction mechanism. We describe here the first structure of a ternary R67 DHFR.DHF.NADP+ catalytic complex, resolved to 1.26 A. This structure provides the first clear picture of how this enzyme, which lacks the active site carboxyl residue that is ubiquitous in Type I DHFRs, is able to function. In the catalytic complex, the polar backbone atoms of two symmetry-related I68 residues provide recognition motifs that interact with the carboxamide on the nicotinamide ring, and the N3-O4 amide function on the pteridine ring. This set of interactions orients the aromatic rings of substrate and cofactor in a relative endo geometry in which the reactive centers are held in close proximity. Additionally, a central, hydrogen-bonded network consisting of two pairs of Y69-Q67-Q67'-Y69' residues provides an unusually tight interface, which appears to serve as a "molecular clamp" holding the substrates in place in an orientation conducive to hydride transfer. In addition to providing the first clear insight regarding how this extremely unusual enzyme is able to function, the structure of the ternary complex provides general insights into how a mutationally challenged enzyme, i.e., an enzyme whose evolution is restricted to four-residues-at-a-time active site mutations, overcomes this fundamental limitation.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_18052202}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 18052202 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_18052202}} |
| | | | |
| | ==About this Structure== | | ==About this Structure== |
| Line 33: |
Line 37: |
| | [[Category: Plasmid]] | | [[Category: Plasmid]] |
| | [[Category: Trimethoprim resistance]] | | [[Category: Trimethoprim resistance]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun 4 09:52:48 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 13:59:42 2008'' |
Revision as of 10:59, 27 July 2008
Template:STRUCTURE 2rk2
DHFR R-67 complexed with NADP
Template:ABSTRACT PUBMED 18052202
About this Structure
2RK2 is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.
Reference
Crystal structure of a type II dihydrofolate reductase catalytic ternary complex., Krahn JM, Jackson MR, DeRose EF, Howell EE, London RE, Biochemistry. 2007 Dec 25;46(51):14878-88. Epub 2007 Dec 4. PMID:18052202
Page seeded by OCA on Sun Jul 27 13:59:42 2008
